Health Condition 1: O111- -2146826259 Health Condition 2: O139- Gestational [pregnancy-induced] hypertension without significant proteinuria, unspecified trimester Health Condition 3: O140- Mild to moderate pre-eclampsia Health Condition 4: O100- Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium
Conditions
Interventions
Intervention1: DETECTING SERUM PLACENTAL GROWTH FACTOR LEVELS IN HYPRTENSIVE PREGNANT WOMEN: DRAWING BLOOD FROM WOMEN DIAGNOSED WITH SPECIFIED HYPERTENSIVE DISORDERS OF PREGNANCY. DETECTING SERUM PLAC
Sponsors
DR RAKSHITHA RAGHAVENDRA
Eligibility
Inclusion criteria
Inclusion criteria: WOMEN BETWEEN THE AGES OF 18 AND 45 WHO PRESENTED WITH HYPERTENSIVE DISORDERS OF PREGNANCY BETWEEN 28 AND 40 WEEKS OF PREGNANCY WHILE CARRYING A LIVE, SINGLETON FOETUS THE HYPERTENSIVE DISORDERS BEING: 1) PRE ECLAMPSIA 2) CHRONIC HYPERTENSION 3) CHRONIC HYPERTENSION WITH SUPERIMPOSED PRE ECLAMPSIA 4) GESTATIONAL HYPERTENSION
Exclusion criteria
Exclusion criteria: 1) WOMEN WITH PRE DIAGNOSED ECLAMPSIA 2) WOMEN WITH MULTIFETAL GESTATION 3) WOMEN BEARING FETUSES WITH INTRA UTERINE DEMISE 4) WOMEN WITH FETUSES BEARING CONGENITAL ANOMALIES
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TO ASSESS THE CORRELATION BETWEEN CIRCULATING LEVELS OF SERUM PLACENTAL GROWTH FACTOR IN HYEPRTENSIVE GESTATIONAL WOMEN WITH ADVERSE MATERNAL OUTCOMES AND TO ESTABLISH THE NEED FOR PLACENTAL GROWTH FACTOR AS A SEVERITY MARKER IN ASSESSING ADVERSE MATERNAL OUTCOMESTimepoint: APRIL 2023 TO DECEMBER 2024 | — |
Secondary
| Measure | Time frame |
|---|---|
| SECONDARY OUTCOME MEASURES THE COST EFFECTIVENESS IN DIAGNOSING ADVERSE MATERNAL OUTCOMES AND TO ESTABLISH THE NEED FOR PLACENTAL GROWTH FACTOR AS A SEVERITY MARKER IN ASSESSING ADVERSE MATERNAL OUTCOMESTimepoint: APRIL 2023 TO DECEMBER 2024 | — |
Countries
India
Contacts
Public ContactDR SHAILAJA R BIDRI
SHRI B.M.PATIL MEDICAL COLLEGE HOSPITAL AND RESEARCH CENTRE, VIJAYPURA 586103
Outcome results
None listed